$ADAPY 4 SEC Filings

Filed On	Filing
03 Sep 2025	Form 4: Wood Gavin, Chief Financial Officer Sold 96,000 shares ($950)
29 Aug 2025	Form 4: Bertrand William C Jr, Chief Operating Officer Sold 207,000 shares ($2.09K)
19 Aug 2025	Form 4: Behbahani Ali, Director Sold 4,828,206 shares ($53.1K) · Sold 14,671,794 shares ($176K)
30 Jul 2025	Form 4: EcoR1 Capital, Llc, 10% owner Sold 33,931,740 shares ($3.82M) · Sold 2,687,460 shares ($272K) · Sold 27,433,338 shares ($2.8M)
20 Feb 2025	Form 4: Bertrand William C Jr, Chief Operating Officer Granted 2,686,728 Option to purchase Ordinary Shares
20 Feb 2025	Form 4: Brewer Joanna Elizabeth, Chief Scientific Officer Granted 2,686,728 Option to purchase Ordinary Shares
20 Feb 2025	Form 4: Lunger John, Chief Patient Supply Officer Granted 2,686,728 Option to purchase Ordinary Shares
20 Feb 2025	Form 4: Piccina Cintia, Chief Commercial Officer Granted 2,686,728 Option to purchase Ordinary Shares
20 Feb 2025	Form 4: Norry Elliot, Chief Medical Officer Granted 2,686,728 Option to purchase Ordinary Shares
20 Feb 2025	Form 4: Rawcliffe Adrian, Director Granted 8,572,080 Option to purchase Ordinary Shares
17 Jan 2025	Form 4: Norry Elliot, Chief Medical Officer Sold 5,584 shares ($3.24K)
17 Jan 2025	Form 4: Lunger John, Chief Patient Supply Officer Sold 5,584 shares ($3.24K)
17 Jan 2025	Form 4: Bertrand William C Jr, Chief Operating Officer Sold 5,584 shares ($3.24K)
17 Jan 2025	Form 4: Rawcliffe Adrian, Director Sold 30,601 shares ($17.8K)
15 Jan 2025	Form 4: Rawcliffe Adrian, Director Sold 30,473 shares ($17.9K) · Sold 29,096 shares ($16.7K)
15 Jan 2025	Form 4: Piccina Cintia, Chief Commercial Officer Sold 12,991 shares ($7.47K)
15 Jan 2025	Form 4: Norry Elliot, Chief Medical Officer Sold 12,392 shares ($7.29K) · Sold 9,803 shares ($5.63K)
15 Jan 2025	Form 4: Lunger John, Chief Patient Supply Officer Sold 9,739 shares ($5.73K) · Sold 9,803 shares ($5.63K)
15 Jan 2025	Form 4: Bertrand William C Jr, Chief Operating Officer Sold 9,739 shares ($5.73K) · Sold 9,803 shares ($5.63K)
01 Jul 2024	Form 4: Behbahani Ali, Director Granted 1,144,686 Option to purchase Ordinary Shares

Comments